Showing results (1-10 of 87) with videos related to
Sort By:
Pageof 9
Current Treatment Options in Oncology|August 7, 2012
Adoptive immunotherapy of advanced melanomaRonnie Shapira-Frommer, Jacob SchachterCancer Journal (Sudbury, Mass.)|November 21, 2015
Tumor-Infiltrating Lymphocytes: Clinical ExperienceMichal J Besser, Ronnie Shapira-Frommer, Jacob SchachterJournal of Lower Genital Tract Disease|April 27, 2026
Vulvar and Vaginal Melanoma: Real-world Clinical Outcomes and Prognostic Differences From a Single-center ExperienceNethanel Asher, Shirly Grynberg, Jacob Schachter, et al.European Radiology|March 26, 2014
CT halo sign as an imaging marker for response to adoptive cell therapy in metastatic melanoma with pulmonary metastasesShai Shrot, Jacob Schachter, Ronnie Shapira-Frommer, et al.Medical Oncology (Northwood, London, England)|May 16, 2013
Tumor lysis syndrome and malignant melanomaMeir Mouallem, Noa Zemer-Wassercug, Eitan Kugler, et al.Cancers|July 2, 2021
Immunotherapy Discontinuation in Metastatic Melanoma: Lessons from Real-Life Clinical ExperienceNethanel Asher, Noa Israeli-Weller, Ronnie Shapira-Frommer, et al.Cancers|June 10, 2023
Better Late Than Never: The Impact of Steroidal Treatment on the Outcome of Melanoma Patients Treated with ImmunotherapyNeta Bar-Hai, Guy Ben-Betzalel, Ronen Stoff, et al.European Journal of Cancer (Oxford, England : 1990)|January 17, 2019
Immunotherapy comes of age in octagenarian and nonagenarian metastatic melanoma patientsGuy Ben-Betzalel, Yael Steinberg-Silman, Ronen Stoff, et al.Frontiers in Oncology|June 5, 2023
Real world evidence of Lenvatinib + anti PD-1 as an advanced line for metastatic melanomaRonen Stoff, Nethanel Asher, Shachar Laks, et al.Therapeutic Advances in Medical Oncology|November 7, 2022
Radiotherapy may augment response to immunotherapy in metastatic uveal melanoma patientsShirly Grynberg, Ronen Stoff, Nethanel Asher, et al.Pageof 9